Scienture announces U.S. FDA approval of NDA for SCN-102
Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...
MPR18h
FDA Approves Losartan Oral Suspension Arbli
The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...